{"id":115452,"date":"2021-06-01T09:00:00","date_gmt":"2021-06-01T09:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2876447"},"modified":"2021-06-01T09:00:00","modified_gmt":"2021-06-01T09:00:00","slug":"myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/","title":{"rendered":"Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight"},"content":{"rendered":"<p><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><span style=\"font-weight: 400;\"><img decoding=\"async\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Myopia%20Progression%20Market%20Insights-01.jpg?1622522306758\" alt=\"Myopia Progression Market Insights-01\" \/><\/span><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/myopia-progression-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Progression Report<\/strong><\/a><span style=\"font-weight: 400;\"> delivers an in-depth understanding of the Myopia Progression, historical and forecasted epidemiology as well as the Myopia Progression market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><strong>Some Key Highlights from the<\/strong> <a href=\"https:\/\/www.delveinsight.com\/sample-request\/myopia-progression-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Progression Market Report<\/strong><\/a><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to Morgan et al. (2017), the prevalence of myopia in young adults is about <\/span><strong>80&ndash;90%<\/strong><span style=\"font-weight: 400;\">, with a strong prevalence of high myopia in the same age group (<\/span><strong>10-20 percent<\/strong><span style=\"font-weight: 400;\">).<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to a report by Nemeth J. et al titled &#8220;Update and Guidance on Management of Myopia&#8221; (2021), average annual progression rates for myopia and axial length in White European children were <\/span><strong>0.41 D<\/strong><span style=\"font-weight: 400;\"> and <\/span><strong>0.30 mm<\/strong><span style=\"font-weight: 400;\"> between 6 and 16 years of age, and <\/span><strong>0.16 D<\/strong><span style=\"font-weight: 400;\"> and <\/span><strong>0.15 mm<\/strong><span style=\"font-weight: 400;\"> between 12 and 22 years of age.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key Pipeline therapies in the Myopia Progression market include NVK-002 (Nevakar)<\/span><strong>, Micropine <\/strong><span style=\"font-weight: 400;\">(Eyenovia Bio),<\/span><strong> SYD-101 <\/strong><span style=\"font-weight: 400;\">(Sydnexis),<\/span><strong> DE-127 <\/strong><span style=\"font-weight: 400;\">(Santen Pharmaceutical)<\/span> <span style=\"font-weight: 400;\">and others.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Key Companies involved in the Myopia Progression are <\/span><strong>Nevakar, Eyenovia Bio, Sydnexis, Santen Pharmaceutical,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">During the study period, 2018&ndash;2030, the demand for Myopia Progression is expected to grow.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Request Sample Page @ <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/myopia-progression-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Progression Market Insights<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">The<\/span> <a href=\"https:\/\/www.delveinsight.com\/report-store\/myopia-progression-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Progression market report<\/strong><\/a><span style=\"font-weight: 400;\"> covers existing clinical practises, new drugs, individual therapies&#8217; market share, and current and forecasted Myopia Progression market sizes in the 7MM (the United States, the EU5, Germany, Italy, Spain, and France), as well as Japan.<\/span><\/p>\n<p><strong>Myopia Progression: Disease Overview<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Myopia is a group of ocular conditions in which the eye&#8217;s far point is closer to the retina than infinity. It is rapidly spreading across the world and posing a significant public health threat. As a result, refractive error is identified as one of the top five causes of blindness and visual impairment in the world by the global initiative to eliminate avoidable blindness.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">One of the most important risk factors for myopia is age, and visual stress caused by detailed work, such as reading or using a device, contributes to the development and progression of myopia over time.<\/span><\/p>\n<p><strong>Myopia Progression Epidemiology Segmentation<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Myopia Prevalence<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Myopia Specific-Severity Prevalence<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Myopia Progression Prevalence<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Myopia Progression Diagnosed and Treated Cases<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">To know more about epidemiology visit, <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/myopia-progression-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Progression Epidemiology<\/strong><\/a><\/p>\n<p><strong>Myopia Progression Treatment Landscape<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">There are no licensed treatments for myopia, so the only way to stop it from getting worse is to use optical correction such as:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Bifocal Spectacle Lenses<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Progressive Addition Spectacle Lenses<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Under-Correction<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Orthokeratology<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Multifocal Contact Lenses<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Increased Exposure to Outdoor Activities<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Use of Atropine eye drops<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/myopia-progression-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Progression Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">New therapies are expected to join the Myopia Progression market from companies such as Nevakar, Eyenovia Bio, Sydnexis, and Santen Pharmaceutical, among others.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">In the forecast period 2018-30 in the 7MM, the launch of NVK-002 (Nevakar), Micropine (Eyenovia Bio), SYD-101 (Sydnexis), and DE-127 (Santen Pharmaceutical) are expected to give the Myopia Progression market a major boost.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Furthermore, the Myopia Progression market is being propelled forward by extensive R&amp;D in the domain, as well as rising Myopia Progression prevalence.<\/span><\/p>\n<p><strong>Myopia Progression Pipeline Therapies and Key Companies<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">NVK-002: Nevakar<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Micropine: Eyenovia Bio<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">SYD-101: Sydnexis<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">DE-127: Santen Pharmaceutical<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">To get more details about emerging drugs and companies visit, <\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/myopia-progression-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Progression Pipeline Drugs and Major Players<\/strong><\/a><\/p>\n<p><strong>Table of Contents<\/strong><\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\">\n<tbody>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">1.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Key Insights<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">2.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Report Introduction<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">3.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression Market Overview at a Glance<\/span><\/td>\n<\/tr>\n<tr style=\"height: 16px;\">\n<td style=\"width: 7.64706%; height: 16px;\">4.<\/td>\n<td style=\"width: 92.3529%; height: 16px;\"><span style=\"font-weight: 400;\">Executive Summary of Myopia Progression<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">5.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression: Disease Background and Overview<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">6.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression: Epidemiology and Patient Population<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">7.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Control of Myopia<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">8.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Organizations contributing towards Myopia<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">9.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression: Patient Journey<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">10.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression: Case Reports<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">11.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression Emerging Therapies<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">12.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia&nbsp; Progression: Seven Major Market Analysis<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">13.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">KOL Views<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">14.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression Market Drivers<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">15.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression Market Barriers<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">16.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">SWOT Analysis<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">17.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Myopia Progression Unmet Needs<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">18.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Appendix<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">19.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">DelveInsight Capabilities<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">20.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">Disclaimer<\/span><\/td>\n<\/tr>\n<tr style=\"height: 17px;\">\n<td style=\"width: 7.64706%; height: 17px;\">21.<\/td>\n<td style=\"width: 92.3529%; height: 17px;\"><span style=\"font-weight: 400;\">About DelveInsight<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Know more about report offering @ <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/myopia-progression-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Progression Market<\/strong><\/a><\/p>\n<p><strong>Related Reports<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/myopia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myopia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Myopia &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Myopia, historical and forecasted epidemiology as well as the Myopia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/adult-myopia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Adult Myopia<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Adult Myopia<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Bayer AG, Genentech,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/centronuclear-myopathy-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Centronuclear Myopathy Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&rsquo;s <\/span><strong>&lsquo;Centronuclear Myopathy Market Insights, Epidemiology, and Market Forecast-2030&rsquo;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Centronuclear Myopathy, historical and forecasted epidemiology as well as the Centronuclear Myopathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/inclusion-body-myositis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Inclusion Body Myositis Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Inclusion Body Myositis &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221; <\/strong><span style=\"font-weight: 400;\">report delivers an in-depth understanding of the Inclusion Body Myositis, historical and forecasted epidemiology as well as the Inclusion Body Myositis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/mitochondrial-myopathies-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Mitochondrial Myopathies Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Mitochondrial Myopathies &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Mitochondrial Myopathies , historical and forecasted epidemiology as well as the Mitochondrial Myopathies market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/myocardial-infarction-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myocardial Infarction Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Myocardial Infarction &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Myocardial Infarction, historical and forecasted epidemiology as well as the Myocardial Infarction market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/myocarditis-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myocarditis<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Myocarditis<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><span style=\"font-weight: 400;\">Cardiol Therapeutics, among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/myotonic-dystrophy-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Myotonic Dystrophy Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Myotonic Dystrophy &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Myotonic dystrophy, historical and forecasted epidemiology as well as the Myotonic dystrophy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/sporadic-inclusion-body-myositis-sibm-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Sporadic Inclusion Body Myositis Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Sporadic Inclusion Body Myositis (sIBM) &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221; <\/strong><span style=\"font-weight: 400;\">report delivers an in-depth understanding of the Sporadic Inclusion Body Myositis (sIBM), historical and forecasted epidemiology as well as the Sporadic Inclusion Body Myositis (sIBM) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/sample-request\/multiple-myeloma-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Multiple Myeloma<\/strong><strong> Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Multiple Myeloma<\/span><span style=\"font-weight: 400;\"> Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Johnson &amp; Johnson, Amgen,&nbsp; BioLineRx, Bristol-Myers Squibb, ExCellThera, Pfizer,&nbsp; Takeda, Precision BioSciences,&nbsp; Poseida Therapeutics,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/consulting\/market-assessment-services?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Get in touch with our Business executive for Competitive Insights and Due Diligence<\/strong><\/a><strong> Services<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">About<\/span><a href=\"https:\/\/www.delveinsight.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"> <strong>DelveInsight<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform<\/span><a href=\"https:\/\/www.pharmdelve.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"> <strong>PharmDelve<\/strong><span style=\"font-weight: 400;\">.<\/span><\/a><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/myopia-progession-epidemilogy\/\" rel=\"tag\">Myopia Progession Epidemilogy<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/myopia-progression-key-companies\/\" rel=\"tag\">Myopia Progression Key Companies<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/myopia-progression-disease\/\" rel=\"tag\">Myopia Progression Disease<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/myopia-progression-pipeline-therapies\/\" rel=\"tag\">Myopia Progression Pipeline Therapies<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/myopia-progession-market-size\/\" rel=\"tag\">Myopia Progession Market Size<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.delveinsight.com\/<\/a><br \/><b>Contact Information:<\/b><\/p>\n<p><span style=\"font-weight: 400;\">Sandeep Joshi&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">info@delveinsight.com&nbsp;<\/span><\/p>\n<p><span style=\"font-weight: 400;\">+1(919)321-6187&nbsp;<\/span><\/p>\n<p><a href=\"http:\/\/www.delveinsight.com\"><span style=\"font-weight: 400;\">www.delveinsight.com<\/span><\/a><\/p>\n<p><strong>Connect With Us at:<\/strong><\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><strong>LinkedIn<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"> <strong>Facebook<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"> <strong>Twitter<\/strong><\/a><\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p><p><span style=\"font-weight: 400;\">Sandeep Joshi\u00a0<\/span><\/p>\n<\/p>\n<p><span style=\"font-weight: 400;\">info@delveinsight.com\u00a0<\/span><\/p>\n<\/p>\n<p><span style=\"font-weight: 400;\">+1(919)321-6187\u00a0<\/span><\/p>\n<\/p>\n<p><a href=\"http:\/\/www.delveinsight.com\"><span style=\"font-weight: 400;\">www.delveinsight.com<\/span><\/a><\/p>\n<\/p>\n<p><strong>Connect With Us at:<\/strong><\/p>\n<\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><strong>LinkedIn<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"> <strong>Facebook<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"> <strong>Twitter<\/strong><\/a><\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/\">Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>DelveInsight&rsquo;s Myopia Progression Report delivers an in-depth understanding of the Myopia Progression, historical and forecasted epidemiology as well as the Myopia Progression market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some Key Highlights from the Myopia Progression Market Report According to Morgan et al. (2017), the prevalence [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/\">Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-115452","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight - Business\" \/>\n<meta property=\"og:description\" content=\"DelveInsight&rsquo;s Myopia Progression Report delivers an in-depth understanding of the Myopia Progression, historical and forecasted epidemiology as well as the Myopia Progression market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some Key Highlights from the Myopia Progression Market Report According to Morgan et al. (2017), the prevalence [&hellip;] The post Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-01T09:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/\",\"name\":\"Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png\",\"datePublished\":\"2021-06-01T09:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/","og_locale":"en_US","og_type":"article","og_title":"Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight - Business","og_description":"DelveInsight&rsquo;s Myopia Progression Report delivers an in-depth understanding of the Myopia Progression, historical and forecasted epidemiology as well as the Myopia Progression market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Some Key Highlights from the Myopia Progression Market Report According to Morgan et al. (2017), the prevalence [&hellip;] The post Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/","og_site_name":"Business","article_published_time":"2021-06-01T09:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/","url":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/","name":"Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png","datePublished":"2021-06-01T09:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/01\/myopia-progression-pipeline-drugs-and-key-companies-market-insights-report-analysis-of-epidemiology-segmentation-treatment-landscape-and-market-size-by-delveinsight\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Myopia Progression Pipeline Drugs and Key Companies Market Insights Report: Analysis of Epidemiology Segmentation, Treatment Landscape and Market Size By DelveInsight"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"https:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115452","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=115452"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115452\/revisions"}],"predecessor-version":[{"id":115453,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/115452\/revisions\/115453"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=115452"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=115452"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=115452"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}